Trials / Recruiting
RecruitingNCT06388785
A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia
Post-vaccination Surveillance for Monitoring the Adverse Events Following Immunisation With QDENGA in a Real-world Setting in Malaysia (PRIME-Q)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Takeda · Industry
- Sex
- All
- Age
- 4 Years
- Healthy volunteers
- Accepted
Summary
The main aim of this study is to collect the number and type of medical problems (adverse events) after vaccination with QDENGA in Malaysia and to learn more about such medical problems after vaccination. Another aim of this study is to collect the number of persons vaccinated with QDENGA who need to stay in the hospital because of severe dengue fever. No vaccination will be given as part of this study. The study will only collect data of persons already vaccinated with QDENGA who agree to participate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | This is a non-interventional study. |
Timeline
- Start date
- 2024-09-26
- Primary completion
- 2027-05-08
- Completion
- 2027-05-08
- First posted
- 2024-04-29
- Last updated
- 2025-06-12
Locations
2 sites across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT06388785. Inclusion in this directory is not an endorsement.